Technical Data
D1500-01A
DcR2 (TRAIL-R4, TRUNDD, Decoy Receptor2, TNF receptor related receptor for TRAIL, TNFRSF10D, TRAIL receptor 4, TRAIL receptor with a truncated death domain, TRUNDD, Tumor necrosis factor receptor superfamily member 10D precursor)
Description:
Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL, and DcR1/TRID is a decoy receptor. Another member of the TRAIL receptor family was more recently identified and designated DcR2, TRAIL-R4, or TRUNDD. DcR2 has an extracellular TRAIL-binding domain but lacks intracellular death domain and does not induce apoptosis. Like DR4 and DR5, DcR2 transcript is widely expressed in normal human tissues. Overexpression of DcR2 attenuated TRAIL-induced apoptosis.

Applications:
Suitable for use in Flow Cytometry, Immunocytochemistry, Immunohistochemistry and Immunoprecipitation. Other applications have not been tested.

Recommended Dilutions:
Immunohistochemistry: Frozen sections
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG16D348Highly Purified
SizeStorageShippingSourceHost
100ug-20°CBlue IceHumanMouse
Concentration:
~1mg/ml
Immunogen:
Recombinant human TRAIL-R4 (DcR2).
Purity:
95% (SDS-PAGE)
Form
Supplied as a liquid in PBS, 0.05% sodium azide.
Specificity:
Recognizes human TRAIL-R4. Does not cross react with human TRAIL-R1, -R2 or -R3.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. B. Washburn, et al.; J. Immunol. 170: 1814 (2003) 2. P. Secchiero, et al.; Blood 103: 517 (2004) 3. T.M. Ganten, et al.; Cell Death Differ. 11 Suppl 1, S86 (2004) 4. T. Wachter, et al.; J. Biol. Chem. 279: 52824 (2004)